Mustang Bio, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Stockholders' Equity (Warrants Activity and Induced Warrant Exercise) (Details)

v3.25.1

Stockholders' Equity (Warrants Activity and Induced Warrant Exercise) (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2024	Feb. 10, 2025	Feb. 05, 2025
Stockholders' Equity
Warrants Outstanding, beginning	1,576,919
Warrants Exercised	(670,000)
Warrants Granted	7,637,889
Warrants Outstanding, ending	8,544,808	1,576,919
Weighted Average Exercise Price (in dollars per share)	$ 4.63	$ 14.56
Weighted Average Exercise Price , Exercised during the period (in dollars per share)	0
Weighted Average Exercise Price , Granted during the period (in dollars per share)	$ 2.17
Warrants outstanding, remaining contractual life	2 years 9 months 14 days	3 years 1 month 20 days
Warrants granted, remaining contractual life	2 years 6 months 7 days
Number of warrants outstanding	8,544,808	1,576,919
February 2025 Public Offering
Stockholders' Equity
Weighted Average Exercise Price (in dollars per share)				$ 0.0001
Prefunded Warrants
Stockholders' Equity
Warrants Outstanding, beginning
Warrants Exercised	670,000
Warrants Outstanding, ending	1,492,807
Weighted Average Exercise Price (in dollars per share)	$ 0.0001
Number of warrants outstanding	1,492,807
Prefunded Warrants \| February 2025 Public Offering
Stockholders' Equity
Warrants issued			2,162,807	2,162,807
Series C1 And Series C2 Warrants \| February 2025 Public Offering
Stockholders' Equity
Warrants issued			5,315,614
Placement Agents Warrants
Stockholders' Equity
Warrants issued			159,468
Placement Agents Warrants \| February 2025 Public Offering
Stockholders' Equity
Weighted Average Exercise Price (in dollars per share)				$ 3.7625
Warrants issued				159,468

- Definition

The number of warrants or rights exercised during the period.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
Namespace Prefix:	mbio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of warrants or rights granted during the period.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWarrantsGrantedDuringPeriod
Namespace Prefix:	mbio_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants that were exercised during the period.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisedDuringPeriod
Namespace Prefix:	mbio_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants that were granted during the period.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWeightedAverageExercisePriceGrantsDuringPeriod
Namespace Prefix:	mbio_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average remaining contractual life for warrants outstanding.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWeightedAverageRemainingContractualLife
Namespace Prefix:	mbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average remaining contractual life for warrants granted during the period.

+ References

No definition available.

+ Details

Name:	mbio_ClassOfWarrantOrRightWeightedAverageRemainingContractualLifeGrantsInPeriod
Namespace Prefix:	mbio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=mbio_February2025PublicOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=mbio_PrefundedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=mbio_SeriesC1AndSeriesC2WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=mbio_PlacementAgentsWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: